Fulcrum Therapeutics, Inc.
SEC Filing List
FULC CIK: 0001680581
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Ezekowitz Alan | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/30/2026 | |
| 144 | Filing for proposed sale of securities u... | Morgan Stanley Smith Barney LLC Executive Services /FA | 06/26/2026 | ||
| 8-K | Current report filing | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/25/2026 | |
| SCHEDULE 13G | SHARTSIS FRIESE LLP /fa | 06/25/2026 | |||
| SCHEDULE 13G | SHARTSIS FRIESE LLP /fa | 06/25/2026 | |||
| 8-K | Current report filing | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/11/2026 | |
| SCHEDULE 13G | SECUREX FILINGS /fa | 06/10/2026 | |||
| 8-K | Current report filing | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/04/2026 | |
| 8-K | Current report filing | Fulcrum Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 06/01/2026 | |
| SCHEDULE 13G/A | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/15/2026 | |||
| No record found. | |||||
| Load More | |||||
